Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dexcom (DXCM) Gross Profit (2016 - 2025)

Historic Gross Profit for Dexcom (DXCM) over the last 17 years, with Q4 2025 value amounting to $792.7 million.

  • Dexcom's Gross Profit rose 2087.53% to $792.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.8 billion, marking a year-over-year increase of 1491.67%. This contributed to the annual value of $2.8 billion for FY2025, which is 1491.67% up from last year.
  • Per Dexcom's latest filing, its Gross Profit stood at $792.7 million for Q4 2025, which was up 2087.53% from $731.4 million recorded in Q3 2025.
  • Over the past 5 years, Dexcom's Gross Profit peaked at $792.7 million during Q4 2025, and registered a low of $343.9 million during Q1 2021.
  • Moreover, its 5-year median value for Gross Profit was $554.2 million (2023), whereas its average is $554.6 million.
  • Per our database at Business Quant, Dexcom's Gross Profit soared by 4681.45% in 2021 and then tumbled by 473.29% in 2024.
  • Quarter analysis of 5 years shows Dexcom's Gross Profit stood at $472.6 million in 2021, then rose by 14.54% to $541.3 million in 2022, then rose by 21.3% to $656.6 million in 2023, then fell by 0.12% to $655.8 million in 2024, then rose by 20.88% to $792.7 million in 2025.
  • Its Gross Profit stands at $792.7 million for Q4 2025, versus $731.4 million for Q3 2025 and $688.8 million for Q2 2025.